In progressive phenotype, CXCL13 showed a correlation with disease activity and IgG-index and intrathecal B-cell response [21]; this may be important considering that the presence of leptomeninges infiltrating B-cells represents a culprit of neuropathology of progressive forms of MS [45]. This evidence concerns the gene CXCL13 and myeloid sarcoma.